The stock market heads into an interesting round of earnings, led by Walmart, RIvian, and a key Warren Buffett stock.

Director Kevin McLaughlin disclosed the sale of 7,000 shares of the company's common stock on February 12, 2025. The stock currently trades at $57.09, near its 52-week high of $63, after gaining over ...

I will be replicating the latter ETF’s strategy by asking DeepSeek which stocks it thinks will surge this year and then I’ll ...

Engaged Capital exited its stakes in BlackLine (NASDAQ:BL) and Nevro (NYSE:NVRO) and took a new position in Chart Industries (NYSE:GTLS) in Q4 2024, among other moves. The hedge fund, known for its ...

Q4 2024 Management View The company addressed its debt maturities by completing $1.8 billion in secured financings in 2024 and reducing total debt principal by nearly $200 million. This included ...

We’re 1½ months into the new year and all of the major indexes are in the green. Moreover, the big 3 indexes (Dow, S&P 500 and Nasdaq) are on the cusp of setting new all-time highs. The year is off to ...

Saudi Arabia's sovereign wealth fund exited its stake in Walmart (NYSE:WMT), took a new position in DoorDash (NASDAQ:DASH), and more than doubled its holdings in Amazon (NASDAQ:AMZN) in Q4 2024, among ...

Renaissance Technologies took a new stake in Intel (NASDAQ:INTC), exited its position in Arm (NASDAQ:ARM), significantly upped its holdings in Nike (NYSE:NKE) and almost entirely sold out of Alphabet ...

Nvidia's dominance and DeepSeek's rise could impact Advanced Micro Devices, Inc.'s stock price and growth potential. Click ...

Shares of travel booking platform Airbnb (NASDAQ: ABNB) jumped on Friday after the company reported financial results for the ...

Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...

Daiwa has downgraded Advanced Micro Devices (NASDAQ:AMD) to Outperform from Buy and slashed its price target for the stock to $130 from $170, citing weaker-than-expected first-half guidance for 2025.